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Abstract
Poly adenosine diphosphate-ribose polymerase-1 (PARP-1) is a multifunctional enzyme that is involved in two major cellular
responses to oxidative and nitrosative (O/N) stress: detection and response to DNA damage via formation of protein-bound
poly adenosine diphosphate-ribose (PAR), and formation of the soluble 2
nd messenger monomeric adenosine diphosphate-
ribose (mADPR). Previous studies have delineated specific roles for several of PARP-19s structural domains in the context of
its involvement in a DNA damage response. However, little is known about the relationship between the mechanisms
through which PARP-1 participates in DNA damage detection/response and those involved in the generation of monomeric
ADPR. To better understand the relationship between these events, we undertook a structure/function analysis of PARP-1
via reconstitution of PARP-1 deficient DT40 cells with PARP-1 variants deficient in catalysis, DNA binding, auto-PARylation,
and PARP-19s BRCT protein interaction domain. Analysis of responses of the respective reconstituted cells to a model O/N
stressor indicated that PARP-1 catalytic activity, DNA binding, and auto-PARylation are required for PARP-dependent
mADPR formation, but that BRCT-mediated interactions are dispensable. As the BRCT domain is required for PARP-
dependent recruitment of XRCC1 to sites of DNA damage, these results suggest that DNA repair and monomeric ADPR 2
nd
messenger generation are parallel mechanisms through which PARP-1 modulates cellular responses to O/N stress.
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Introduction
Converging evidence from pharmacologic and genetic studies
suggests that the poly adenosine diphosphate-ribose polymerases
PARP-1 and PARP-2 play a central role in cellular responses to
environmental oxidative and nitrosative (O/N) stress [1]. Two
major pathways appear to lie downstream of PARP-1/2
activation: formation of nuclear polymeric adenosine diphos-
phate-ribose (PAR) associated with the cellular response to
oxidant-induced DNA damage (reviewed in [1], see also [2–4]),
and formation of monomeric adenosine diphosphate-ribose
(mADPR) that serves as a 2
nd messenger to induce gating of the
TRPM2 Ca
2+ channel [5–8].
A detailed model for PARP-1 function in the context of O/N
stress-induced DNA damage has emerged in which PARP-1 is
activated by binding of its N-terminal domain (designated the
DNA binding domain or DBD) to oxidant-induced DNA single
strand breaks (SSB) and double strand breaks (DSB) [9]. Activated
and DNA bound PARP-1 catalyzes the conversion of cellular
nicotine adenine dinucleotide (NAD) to long, branched chains of
PAR attached to a wide variety of acceptor proteins in the nucleus.
Notably, the major PAR acceptor is PARP-1 itself, which appears
to accumulate roughly 90% of cellular PAR via PARylation of its
auto-modification domain (AMD) [1]. DNA bound PARylated
PARP-1 and associated proteins are thought to promote relaxation
of the 30 nm chromatin fiber and destabilization of DNA-histone
interactions to allow additional DNA damage response proteins
access to the damaged site [10]. In the case of DNA SSBs, the
combined actions of PAR-ylated PARP-1 and the PARP-1 BRCT
domain contribute to the assembly of a protein complex at the
break site that includes XRCC1, DNA Ligase III and DNA pol-b
[11–16]. In the case of DSBs, PAR/PARP-1 are thought to
promote homologous recombination-mediated repair (HR)
through the recruitment and PARylation of factors involved in
non-homologous end joining (NHEJ) including Ku70 and DNA-
PKcs, resulting in the inhibition of their ability to bind free DNA
ends [17–20].
Much less is known about the biochemical mechanisms of
PARP-1 activation in the context of O/N stress induced formation
of mADPR. Compelling evidence indicates that PARP-1-depen-
dent mADPR formation results in mADPR-mediated activation of
the TRPM2 Ca
2+ channel (Figure 1 and [21–24]). However, there
are no data addressing the biochemical context in which PARP-1
activation leads to mADPR formation, or the relationship between
these mechanisms and PARP-19s involvement in the DNA
damage response. To better define the biochemistry of PARP-
dependent mADPR formation, we reconstituted PARP-1 deficient
DT40 cells with either WT or various mutant forms of PARP-1
(Figure 2), and determined the capacity of each mutant to support
two correlates of O/N stress-induced mADPR formation: NAD
degradation and TRPM2 activation. Our results suggest that
catalytic activity, DNA binding, and an intact auto-PARylation
domain are required for PARP-1-mediated cytosolic mADPR
accumulation in vivo. In contrast, the BRCT domain, which is
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6339required for recruitment of the DNA repair factor XRCC1, was
found to be entirely dispensable. Taken together, these results
suggest that DNA repair complex formation and mADPR 2
nd
messenger accumulation are parallel mechanisms through which
activated PARP-1 signals the presence and extent of O/N stress to
a cell.
Results
Expression of PARP-1 structural mutants in DT40 B
lymphocytes
To dissect the contributions of each of PARP-19s domains to
mADPR accumulation under conditions of O/N stress in vivo,w e
generated a series of human PARP-1 mutants that had been
previously successfully expressed and characterized in vitro (Figure 2
and legend).
Because direct measurement of cellular mADPR is confounded
by the degradation of NAD and/or NADP into mADPR during
nucleotide extraction procedures (reviewed in [25–27]), our
experimental approach utilized two indirect readouts of each
mutant PARP’s ability to support mADPR formation: NAD
degradation and TRPM2-dependent cytosolic Ca
2+ transients.
Degradation of NAD is the sole metabolic pathway leading to the
formationofmADPR,and thus its degradationis directly correlated
with the rate and magnitude of mADPR formation [28–30]. As
discussed above, TRPM2 is a Ca
2+ entry channel that is the
physiologic target of free cytosolic mADPR, and mADPR-medated
TRPM2 activation results in characteristic short latency, large
magnitude cytosolic Ca
2+ transients [5,6,31]. Although cytosolic
Ca
2+ can be influenced by any factor that affects Ca
2+ entry to or
exit from the cytosol, in the DT40 system, large magnitude O/N
stress-induced Ca
2+ transients require the expression of TRPM2 as
Figure 1. PARP-1 synthesizes long, branched chains of poly-mADPR (PAR) on a wide variety of acceptor proteins in the nucleus,
notably PARP-1 itself (which appears to accumulate roughly 90% of cellular PAR). Subsequently, PAR is degraded by Poly-ADP-Ribose-
Glycosylase (PARG) into mADPR, which is assumed to diffuse out of the nucleus and into the cytosol. There it can bind to the ion channel TRPM2,
leading to the influx of cations, including calcium. Additionally, PARP-1 mediates the recruitment of DNA repair proteins to sites of DNA damage
through protein-protein interactions (notably through its BRCT domain) and PARylation. The relationship between PARP-mediated mADPR
degradation and DNA damage repair remains unclear.
doi:10.1371/journal.pone.0006339.g001
Figure 2. human polyADP-ribose polymerase-1 (PARP-1) variants. PARP-1 variants with mutations or deletions of each of hPARP-19s
functional domains were made based on previous successful expression of the mutant construct either in bacteria or eukaryotic cells. Zn – zinc finger
domain. Automod – automodification domain. BRCT – BRCA1 C-terminal homology domain. Catalytic – PARP catalytic domain.
doi:10.1371/journal.pone.0006339.g002
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(Figure 3A, left panel and (30)). Thus, these characteristic Ca
2+
transients can be used as a surrogate marker of cytosolic mADPR
accumulation to the TRPM2 gating threshold.
To allow correlated assessment of NAD degradation and
TRPM2-dependent Ca
2+ transients in a single experimental
system, a TRPM2 expressing PARP-deficient DT40 B lymphocyte
line was chosen as a testbed for the mutant PARPs. To evaluate
the influence of hPARP expression on TRPM2-dependent Ca
2+
responses, PARP-KO cells were transfected with WT human
PARP-1 to generate a panel of clonal cell lines with a range of
hPARP-1 expression (Figure 3A, middle panel). Over the range of
hPARP-1 expression observed in these clones, only small
differences in latency were observed in TRPM2 dependent Ca
2+
Figure 3. Attenuation of PARP-1 catalytic activity correlates with a reduction in O/N stress induced NAD degradation and TRPM2-
dependent Ca
2+ transients. A) Left panel: Calcium transients in DT40 cells are PARP and TRPM2 dependent. The indicated cell lines were
stimulated with 100 mM MNNG, and cytosolic Ca
2+ transients were monitored by ratiometric analysis of Indo-1 fluorescence by FACS. Middle panel:
PARP clones with varying PARP expression levels by western blotting: PARP-deficient DT40 cells were reconstituted with WT human PARP-1, and the
parent PARP-KO line and four clones with a range of expression levels are shown. 50 mg of cellular protein was loaded into each lane of an 8% SDS-
PAGE gel and analyzed by western blotting. Rabbit anti-human PARP-1 polyclonal antibody was used as the primary antibody for immunoblotting of
PARP-1 (1:4000, Alexis Biochemicals), and IR680 conjugated goat anti-rabbit as secondary antibody (1:3000, Licor Inc). Blots were analyzed on a Licor
Odyssey. Right panel: Dependence of TRPM2-dependent Ca
2+ transients on PARP expression level. The four PARP-WT expressing clones from the
middle panel were compared for TRPM2-dependent Ca
2+ transients in response to 100 mM MNNG, as measured by ratiometric analysis of Indo-1
fluorescence by FACS. Time to half maximum F400/F475 showed a standard deviation of 633 seconds: clone #2 with an intermediate level of PARP-1
expression was designated as PARP-WT and used as a positive control for subsequent experiments. B) Left Panel: PARP-Y986H protein expression is
comparable to PARP-WT:5 0mg of cellular protein were loaded into each lane of an 8% SDS-PAGE gel and analyzed by western blotting. Antibodies
were identical to A.) Middle Panel: Relative transcript abundance of PARP-Y986H normalized to PARP-WT, as determined by Q-PCR. Right panel: TRPM2-
dependent whole cell currents are similar in PARP-WT and PARP-Y986H mutant clones. Average whole cell currents were not statistically different from
one another across all cell types. Cells were patched in the whole cell configuration: the pipette solution contained 100 mM mADPR. The I-V
relationship and current development across all cell types was characteristic of TRPM2 and identical to that previously shown by our lab (4). At least 3
whole cell recordings were taken for each cell type. C) Left panel: NAD turnover in PARP-WT and PARP-Y986H cells. Stars indicate a p-value of p#.001
from baseline for all subsequent points. Right panel: TRPM2-dependent Ca
2+ transients in PARP-WT and PARP-Y986H cells after stimulation with
100 mM MNNG, as measured by ratiometric analysis of Indo-1 fluorescence by FACS.
doi:10.1371/journal.pone.0006339.g003
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(Figure 3A – right panel: time to half maximum F400/F475=
327633 sec.), suggesting that across this range of hPARP-1
expression levels, PARP-1 activity is not limiting for accumulation
of free cytosolic mADPR to a level required to initiate TRPM2
gating. Clone #2, with intermediate expression of hPARP-1, was
designated PARP-WT and used as a positive control for subsequent
experiments.
Following transfection of TRPM2 expressing PARP-deficient
DT40 cells with each mutant construct (Figure 2), panels of clones
were selected and TRPM2 and mutant PARP protein expression
were compared to the PARP-WT control cell line selected above.
For each PARP mutant, a clone closely matched to the PARP-WT
cell line for both hPARP-1 by western blot (Figures 3B [left panel],
4A [left panel], and 5A [left panel]) and TRPM2 by whole cell
current amplitude (Figure 3B [right panel], 4A [right panel], and
Figure 4. The effects of DBD mutations on PARP-dependent O/N STRESS induced NAD degradation and TRPM2-dependent Ca
2+
transients. A) PARP-dZF mutant expression levels relative to PARP-WT:Left Panel:5 0mg of cellular protein were loaded into each lane of an 8% SDS-
PAGE gel and analyzed by western blotting. Rabbit anti-human PARP-1 polyclonal antibody was used as the primary antibody for immunoblotting of
PARP-1 (1:4000, Alexis Biochemicals), and IR680 conjugated goat anti-rabbit as secondary antibody (1:3000, Licor Inc). Blots were analyzed on a Licor
Odyssey. Middle Panel: Relative transcript abundance of PARP-dZF mutants normalized to PARP-WT, as determined by Q-PCR. Right panel: TRPM2-
dependent whole cell currents are similar in PARP-WT and PARP-dZF mutant clones. Average whole cell currents were not statistically different from
one another across all cell types. Cells were patched in the whole cell configuration: the pipette solution contained 100 mM mADPR. The I-V
relationship and current development across all cell types was characteristic of TRPM2 and identical to that previously shown by our lab [5]. At least 3
whole cell recordings were taken for each cell type. B) Left panel: NAD turnover in PARP-WT and PARP-dZF1 DT40 cells. PARP-dZF1 did not show NAD
degradation over the course of 30 minutes following application of 100 mM MNNG. Stars indicate a p-value of p#.001 from baseline for all
subsequent points. Right panel: TRPM2-dependent Ca
2+ transients in PARP-WT and PARP-dZF1 DT40 cells after stimulation with 500 mM MNNG, as
measured by ratiometric analysis of Indo-1 stained cells by FACS. No transients were seen in PARP-KO or PARP-dZF1 at 100 mM MNNG (data not
shown). C) Left panel: NAD turnover in PARP-WT and PARP-dZF2 DT40 cells. PARP-dZF2 cells show NAD degradation over the course of 240 minutes
following application of 100 mM MNNG. Stars indicate a p-value of p#.001 from baseline for all subsequent points. Right panel: TRPM2-dependent
Ca
2+ transients in PARP-WT and PARP-dZF2 DT40 cells after stimulation with 100 mM MNNG, as measured by ratiometric analysis of Indo-1 stained cells
by FACS. No transients were seen in PARP-KO or PARP-dZF2 at 100 mM MNNG (data not shown).
doi:10.1371/journal.pone.0006339.g004
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Ca
2+ transients. A) Left Panel: PARP AMD mutant expression levels relative to PARP-WT 50 mg of cellular protein from each cell line were loaded into
each lane of an 8% SDS-PAGE gel and analyzed by western blotting. Rabbit anti-human PARP-1 polyclonal antibody was used as the primary antibody
for immunoblotting of PARP-1 (1:4000, Alexis Biochemicals), and IR680 conjugated goat anti-rabbit as secondary antibody (1:3000, Licor Inc). Blots
were analyzed on a Licor Odyssey. Middle Panel: Relative transcript abundance for PARP AMD mutants normalized to PARP-WT, as determined by Q-
PCR. Right Panel TRPM2 dependent whole cell currents are similar in PARP-WT and PARP AMD mutant clones. Average whole cell currents were not
statistically different from one another across all cell types. Cells were patched in the whole cell configuration: the pipette solution contained 100 mM
mADPR. The I-V relationship and current development across all cell types was characteristic of TRPM2 and identical to that previously [5]. At least 3
whole cell recordings were taken for each cell type. B) Left Panel: NAD turnover in PARP-WT and PARP-dAMD cells. Stars indicate a p-value of p#.001
from baseline for all subsequent points. Right Panel: TRPM2-dependent Ca
2+ transients in PARP-WT and PARP-dAMD cells after stimulation with
100 mM MNNG, as measured by ratiometric analysis of Indo-1 stained cells by FACS. C) Left Panels: NAD turnover in PARP-WT, PARP-dBRCT, and PARP-
nBD cells. Stars indicate a p-value of p#.001 from baseline for all subsequent points. Right Panel: TRPM2-dependent Ca
2+ transients in PARP-WT, PARP-
dBRCT, and PARP-nBD cells after stimulation with 100 mM MNNG, as measured by ratiometric analysis of Indo-1 stained cells by FACS.
doi:10.1371/journal.pone.0006339.g005
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Importantly, taken together with the data from Figure 3A, these
data demonstrate that, absent a significant alteration in function of
a mutant protein relative to WT PARP-1, the range of expression
levels observed in the clones chosen for analysis would not be
expected to significantly impact the rate of O/N-stress induced
mADPR accumulation.
Catalytic activity correlates with PARP-1 NAD
degradation and mADPR accumulation under conditions
of O/N stress
In vitro, a functional PARP-1 catalytic domain is known to be
required for PAR synthesis. In vivo, TRPM2 activation (a surrogate
ofmADPRaccumulation,asdescribedabove)occursearlyinanO/
N stress exposure time course, with onset of gating occurring at time
points when c.a. 15–20% of cellular NAD is degraded [5]. In order
to validate the role of PARP-1 catalytic activity in O/N stress
induced NAD degradation and TRPM2 gating, we generated a
panel of catalytic domain (CD) mutants with varying levels of in
vitro PARP activity [9,32]: hPARP-1 lacking the catalytic domain
(PARP-dCAT), hPARP1 DBD fused directly to the minimal catalytic
domain (PARP-DBDCAT – this mutant can bind DNA but is
catalytically inactive, [33,34, Kupper, 1996 #99,35]], hPARP-1
with ,99% attenuated catalytic activity in vitro (PARP-E988K), or
hPARP-1 with ,90% attenuated catalytic activity in vitro (PARP-
Y986H) (see Figure 2). For functional evaluation, cell lines
expressing each construct (as indicated by their acquired resistance
to hygromycin treatment following transfection) were evaluated for
NAD degradation and their ability to support a TRPM2 dependent
Ca
2+ transient (Figure 3B). Surprisingly, although abundant
transcript was detectable, and these proteins have been reported
as stable in vitro and in other cell systems [9,36], the PARP-E988K
and PARP-dCAT mutants failed to express in DT40 cells, suggesting
a loss of protein stability in the DT40 context. The inactive PARP-
DBDCAT, behaved as predicted, expressing as well as WT PARP
but exhibiting no capacity to support a TRPM2-dependent Ca
2+
transient (data not shown). Consistent with in vitro results suggesting
that its activity is about 90% reduced from WT PARP-1, the PARP-
Y986H mutant resulted in both a detectable but significantly
delayed time course of NAD degradation, and an increased latency
TRPM2-dependent Ca
2+ transient (Figure 3C, left and right
panels). Based on the data shown in Figure 3A, the slightly
decreased expression level ofthe PARP-Y986H mutant would not be
expected, in isolation, to reduce the rate of mADPR accumulation
sufficiently to cause the observed changes. Taken together, these
results directly implicate PARP-1 catalytic activity in the formation
and accumulation of mADPR.
Zinc Finger mutations of the PARP-1 DBD significantly
compromise both NAD degradation and mADPR
accumulation under conditions of O/N stress
PARP-1 has two predicted zinc finger motifs in an N-terminal
region that has been implicated in DNA-binding dependent
activation of PARP-1, and that is designated the DNA binding
domain (DBD). Previous work in vitro and in vivo has suggested that
mutation of the first zinc finger (ZF1) in PARP-19s DBD leads to
loss of DNA binding and PARP activation in response to both
DNA SSBs and DSBs, while mutation of the 2
nd zinc finger (ZF2)
leads to a relatively selective loss of response to SSB’s [34,36,37].
Though there is some evidence that the catalytic domain of PARP
has a very limited activity independent of the DBD [33], neither in
vivo NAD degradation nor mADPR accumulation were examined
in previous studies which addressed DBD function.
To evaluate the role of the DBD in PARP-dependent mADPR
formation in vivo, we studied cells expressing PARP-1 in which two
cysteines in either ZF1 (PARP-dZF1), ZF2 (PARP-dZF2), or both
ZF1 and ZF2 (PARP-dZF12) were replaced with tyrosine residues,
thereby disrupting the structure of the targeted zinc finger(s). Q-
PCR analysis revealed that transcript levels of the two single
mutants PARP-dZF1 and PARP-dZF2 (Figure 4A) were within 1-2
fold those of the PARP-WT control line. However, PARP-dZF1
showed considerably less expression than PARP-dZF2, suggesting a
loss of stability and/or degradation of this mutant. Supporting the
importance of structurally intact zinc fingers to PARP folding in
vivo, PARP-dZF12 showed no protein expression in DT40 cells in
any screened clones (data not shown).
If DNA binding were necessary for PARP-dependent mADPR
accumulation, the PARP-dZF1 mutant, which has little or no
detectable DNA binding capacity, would be expected to show little
or no ability to reconstitute O/N stress-induced NAD degradation
or TRPM2 activation in the DT40 system. Consistent with this
prediction, we observed no detectable reconstitution of NAD
degradation and TRPM2 dependent Ca
2+ transients with the
dZF1 mutant (Figure 4B, left and right panels). While the low
expression level of PARP-dZF1 prevents the unequivocal conclu-
sion that the dZF1 mutant lacks functional activity due to loss of
DNA binding, results from other PARP mutants with comparable
relative expression but retained functional reconstitution (e.g. see
Figure 5, PARP-nBD mutant) suggest that if dZF1 had retained a
significant level of activity, some functional reconstitution would
be expected at the expression level that was achieved.
Using similar reasoning, as the ZF2 mutant retains DNA
binding activity towards SSBs, one would expect attenuated NAD
degradation and TRPM2-dependent Ca
2+ transients, particularly
at lower levels of O/N stress. Consistent with this prediction,
treatment of PARP-dZF2 expressing cells with 100 mM MNNG led
to NAD degradation, but over a prolonged time course in
comparison to PARP-WT cells (Figure 4C, left panel), while the
generation of a TRPM2-dependent Ca
2+ transient required
treatment with 500 mM MNNG (Figure 4C, right panel, no
response was observed with 100 mM MNNG treatment over a
1200 second period of time, data not shown).
Overall, our analyses of the dZF1 and dZF2 mutants suggest
that PARP-recruitment to sites of DNA damage via the DBD is
crucial to both NAD degradation and mADPR mediated TRPM2
gating. They also support previous in vitro data on the relative
importance of each ZF domain in PARP activation: ZF1 function
is required for PARP activation, and ZF1 alone is able to sustain a
reduced level of PARP activation and PARP-dependent NAD
degradation and cytosolic mADPR accumulation when ZF2 is
inactivated.
The BRCT- and non-BRCT- components of the PARP-1
AMD contribute differentially to O/N stress induced NAD
degradation and mADPR accumulation
Previous work has shown that PARP-1 interacts with a wide
variety of proteins through its BRCT domain or PAR moieties
[15,38–40]. Both the BRCT domain and the primary sites of PAR
moiety attachment are found in a region of PARP-1 known as the
automodification domain (AMD). In order to evaluate the
contribution of protein interactions mediated via the AMD
domain to mADPR accumulation, a PARP mutant lacking the
entire AMD domain, PARP-dAMD, was generated. Although a
highly overexpressing clone was used for analysis (Figure 5A),
PARP-deficient DT40 cells reconstituted with the PARP-dAMD
mutant showed a significantly decreased rate of NAD degradation
(Figure 5B, left panel) and a significantly increased latency of
PARP-1 Structure/Function
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2+ transients under conditions of O/N
stress (Figure 5B, right panel), suggesting a significant compromise
of mADPR formation.
The observed compromised mADPR formation could be due
either to functional inactivation of PARP-1 catalytic activity on
account of the large deletion, loss of PARylation sites resulting in
decreased converstion of PAR to mADPR, or loss of protein
interactionsrequiredforgenerationofmADPR.TheBRCTdomain
oftheAMDcontainsnumerouspossibleautomodificationsites(9/15
glutamates found in the AMD are in the BRCT domain) and has
been implicatedinprotein-proteininteractionsof PARP-1,including
its homodimerization (which is thought to be important for catalytic
activity and automodification [41]), recruitment of XRCC1, and
recruitment of PARG (necessary for PAR turnover [10]). A plausible
explanation for the compromised NAD degradation and TRPM2
gating associated with the PARP-dAMD mutant is therefore that
PARP-dAMD is unable to recruit appropriate effector proteins via
the BRCT domain. To test this possibility, we examined PARP-
deficient DT40 cells expressing either of two additional mutant
PARP constructs: PARP-dBRCT, which lacks only the BRCT
portion of the AMD, and PARP-nBD, which retains only the BRCT
domainandhasallotherelementsoftheAMDdeleted(seeFigure1).
Remarkably, PARP-dBRCT, which expressed at the same level as
PARP-WT (Figure 5A), fully reconstituted O/N stress dependent
NAD degradation (Figure 5C, top left panel), and TRPM2
dependent Ca
2+ transients (Figure 5C, right panel). Although
PARP-nBD was expressed at lower level than WT PARP in clone
#2, it was still able to partially reconstitute NAD degradation
(Figure 5C, bottom left panel), and support a TRPM2 dependent
Ca
2+ transient, albeit with a prolonged latency (Figure 5C, right
panel). Taken together, these findings suggest that the AMD has an
importantroleinPARP-1mediatedmADPRaccumulation,butthat
this role is independent of protein interactions mediated by the
BRCT domain.
Discussion
Although the biochemical mechanisms through which PARP-
1/2 are activated to induce PAR synthesis in the context of the
DNA damage response have been established both in vitro and in
vivo, the specifics of how their activation leads to mADPR
accumulation remain largely untested. By reconstituting PARP-1
deficient DT40 cells with either WT or variously mutated PARP-1
isoforms, we here provide in vivo data which define the
contribution of PARP-19s major domains to O/N stress induced
cytosolic mADPR accumulation. Taken together, our results
demonstrate a requirement for PARP-1 catalytic activity, DNA
binding capability, and auto-PARylation for PARP-induced
mADPR accumulation, and indicate that protein interactions
mediated via the BRCT domain are dispensable for this function.
It has previously been shown that PARP-1 accumulation at sites
of DNA damage in vivo is dependent on the integrity of ZF1 [37].
In vitro studies have suggested that ZF1 is required for PARP-1
activation in the presence of both SSBs and DSBs, while ZF2
makes only a minor contribution to activation by SSBs. Our
results support the hypothesis that PARP-mediated mADPR
accumulation is initiated by the same or very similar processes, as
we observed that ZF1 is absolutely required for PARP-1 mediated
mADPR accumulation, while ZF2 makes an important, albeit
smaller, contribution. Given that PARP-dZF2 cannot bind DSBs
yet shows undiminished activation by SSBs in vitro, our results
further suggest that in response to MNNG, PARP-1 mediated
NAD degradation and mADPR accumulation may be occurring
largely in response to SSBs, as MNNG induces primarily SSBs
[42,43]. In the absence of a functional ZF2, a higher concentration
of MNNG is able to detectably activate PARP, an observation
which may reflect a sufficiently high density of SSBs or sufficient
numbers of DSB’s to induce the activation of PARP via ZF1 alone.
Following binding of damaged DNA and activation of PARP-1,
PARP-1 mediates PAR accumulation on itself and other proteins
as well as the formation of a DNA repair complex. Previous data
[9,10] have suggested that the BRCT domain is involved in the
formation of the DNA repair complex, but have not addressed
whether DNA repair complex formation is associated with
mADPR 2
nd messenger formation. Our results demonstrate that
BRCT-dependent interactions are not required for PAR/mADPR
accumulation, suggesting that DNA repair complex formation and
mADPR generation functions are at least parallel, and possibly
independent. Overall, our results extend previous in vitro results
indicating that loss of the BRCT domain does not influence
PARP-1 activity [9], and that interactions mediated by the BRCT
domain are not required for mADPR formation.
Early work on PARP-1 suggested that the AMD is the exclusive
target of PARP-1 automodification. 15 glutamates are present in
the AMD, representing roughly 50% of the total possible auto-
modification targets in PARP-1: of these, 9 are in the BRCT
portion [44–47], and the other 6 in the nBD protion. Nevertheless,
PARP-dBRCT showed no apparent defect in NAD degradation or
induction of TRPM2 dependent Ca
2+ transients. Since the
decrease in our surrogate markers of PARP-1 dependent mADPR
accumulation was much more dramatic for PARP-dAMD than for
PARP-dBRCT, our results further suggest that PARP-1 may
automodify specific glutamates in the nBD regions preferentially.
Alternatively, recently described specific lysine ADP-ribosylation
in the AMD may account for our observations [33]. Although
evidently not absolutely required for mADPR accumulation, such
preferential ADP-ribosylation of specific amino acid residues could
have a role in other aspects of PARP function.
Taken together, our results suggest that the biochemical
mechanisms required for PARP-19s role in O/N stress induced
ADPR formation are very similar or identical to those involved in
PARP-19s participation in the response to DNA damage. ZF1 and
ZF2 work in concert to mediate activation of PARP-1 via binding to
oxidant-induced SSBs and DSB’s. Following DNA binding and
activation, PARP-1 PARylates itself within the non-BRCT portions
of the AMD domain, as well as other proteins. At this point PARP-
19s downstream functional paths appear to diverge, as the BRCT
domaintogetherwith some portion of protein-bound PAR mediates
interactions to assemble a DNA repair complex as a component of
PARP-19s function in the DNA damage response, while other PAR
is apparently degraded by PARG into mADPR, which diffuses into
the cytosol resulting in TRPM2 gating and a Ca
2+ transient.
Materials and Methods
Cell Culture—Wild type DT40 B lymphocytes (DT40 control
cells) and DT40 B lymphocytes constitutively expressing wild type
TRPM2 (DT40-TRPM2 cell line) were cultured at 37uC with 5%
CO2 in RPMI 1640 medium (Mediatech Inc.) supplemented with
10% fetal bovine serum (Mediatech Inc.), 2% chicken serum
(Invitrogen), 10 units/ml penicillin/streptomycin (Mediatech Inc.),
2 mM glutamine (Mediatech Inc.), and b-mercaptoethanol
(50 mM; Sigma). PARP-1-deficient DT40 cells were a generous
gift from Shunichi Takeda.
O/N stress stimulations— Previously, we have shown that MNNG
and H2O2 elicit very similar PARP-1 dependent NAD degradation
and TRPM2 dependent Ca
2+ transients: because MNNG produces
more consistent responses, we chose to use it for all experiments.
PARP-1 Structure/Function
PLoS ONE | www.plosone.org 7 July 2009 | Volume 4 | Issue 7 | e6339Molecular Biology—PARP-deficient cells expressing HA-TRPM2
were previously generated in our lab [5]. PARP constructs were
generated by having subsections of PARP-1 synthesized (Blue
Heron, Inc.) and then cloning these fragments into the pcatalytic
domainNA5TO-hPARP-1 vector previously described [5]: all
constructs were sequenced in their entirety. Stable transfection of
PARP-deficient DT40 B lymphocytes with the various human
PARP-1 constructs (see Figure 2: hPARP-1 cDNA courtesy of Ted
Dawson, The Johns Hopkins University Medical School, [48]) was
carried out using a Bio-Rad Gene-Pulser electroporation apparatus.
Cells (1610
7/0.5 ml of serum-free medium) were pulsed in 0.4-cm
cuvettes with 50 mg of plasmid DNA at 550 V and 25 mF. Clones
were selected in hygromycin (2 mg/ml, Calbiochem). Individual
clones were evaluated for hPARP-1 by western blot and TRPM2
expression via whole cell patch clamp (see below) and western blot.
Calcium Imaging—Changes in cytosolic calcium concentration
were measured by quantitating changes in the ratio of blue/violet
fluorescence (in arbitrary units) from the dye Indo-1 (Molecular
Probes). Briefly, 1610
7cells in 1 mL of media were incubated with
Indo-1 dye (final concentration: 7 mg/ml) for 45 minutes in the
dark at 37uC. Cells were washed twice with 1xPBS (Cellgro) and
resuspended in 1 mL RPMI 1640 medium (as described above)
without phenol red indicator dye. Cells were analyzed for 30
seconds on an LSR II (Becton Dickinson) to establish a baseline,
treated with either 1 or 5 uL 100 mM MNNG (final concentra-
tion: 100 or 500 mM), and analyzed for a total of 1200 seconds. All
recordings were done at room temperature.
Whole Cell Patch Clamp—DT40 cells were adhered to glass
coverslips by a 10-min incubation in serum-free media and then
stored in standard media (see above) until transferred to the
extracellular solution (145 mM NaCl, 2.8 mM KCl, 10 mM CsCl,
1 mM CaCl2, 2 mM MgCl2, 10 mM glucose, 10 mM HEPES,
pH 7.4). Patch clamp experiments were carried out using a Zeiss
Axiovert microscope, equipped with Eppendorf micromanipula-
tors and stage control. Patch clamp recordings were taken using an
EPC10 amplifier (Heka) and a Dell computer running Pulse. Cells
were patched with borosilicate glass pipettes pulled with a Sutter
instruments P-97 micropipette puller: pipettes had 3–8 MV tips.
Pipettes were filled with intracellular solution containing 145 mM
cesium glutamate, 8 mM NaCl, 1 mM MgCl2, and 10 mM
HEPES, pH 7.4, with or without 100 mM mADPR. Following
formation of a gigaseal, the membrane patch was ruptured by
suction, and recordings were taken for 100–300 s. 50-ms voltage
ramps were run every 2 s from 2100 to +100 mV. Data analysis
was performed using Pulse and Excel software.
NAD Assay—The NAD assay was performed according to the
method of Jacobson and Jacobson (reviewed in [27]) with minor
modifications. Briefly, 1610
6 cells were resuspended in 290 mlo f
media in a single well of a 96-well plate. Wells received 10 mlo f
3 mM MNNG (for a final concentration of 100 mM) at 5-min
intervals over a total time course of 30 or 240 min (three replicates
per time point). Cells were pelleted at 1500 rpm for 5 min and lysed
in 100 mlo f0 . 5NH C l O 4 for 15 min on ice and in the dark. Cellular
debris was removed by centrifugation at 1500 x g for 10 min. On ice
and in the dark, 100 ml of KOH and 100 mlo fK 2HPO4/KH2PO4,
pH 7.2, were added to the supernatant and incubated for 15 min.
The KClO4 precipitate was removed via centrifugation at 1500 x g
for 10 min.25 ml of the supernatant was incubated for 5 min at 37uC
with 2 mM phenazine ethosulfate, 0.5 mM 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide, 50 mM EDTA, 600 mM
ethanol, and 120 mM Bicine, pH 7.8. 12.5 ml of alcohol dehydro-
genase (1 mg/ml, Sigma) were added, and the plate was incubated
for a further 20 min at 37uC. The plate was then read (absorbance)
for1 s/wellusinga VICTOR3 platereaderat570 nm.Data analysis
wasperformed in MicrosoftExcel and GraphPad Prism. Fluctuations
among untreated series from all cell lines between 80 and 120% of
base line were observed, which were judged to lack practical
relevance. To control for these, a conservative statistical significance
levelofp,0.001 was chosen, as deviations from baseline in untreated
controls in individual plates did not reach statistical significance by
this criterion.
Western Blotting—Western blotting was performed in 8%
acrylamide (29:1) SDS-polyacrylamide gels. Lysis of cells was
performed in RIPA lysis buffer with complete mini protease
inhibitor cocktail (Roche). Debris was removed by centrifugation
at 20,000 x g for 15 minutes at 4uC, and protein in the supernatant
was quantified using a bradford protein assay (BioRad). Immu-
noprecipitation of HA-TRPM2 was done on 500 mg of protein
from relevant cell lines incubated with HA antibody (1:100, Cell
Signaling) overnight and precipitated using protein A beads.
Nuclear/Cytoplasmic extraction was performed as follows: Cells
were vortexed 3 times in Buffer S10 (10 mM HEPES, pH7.9,
10 mM KCl, and 0.1 mM EDTA) and centrifuged at 20,000 x g
for 10 minutes at 4uC. The resulting pellet was then vortexed 3
times in Buffer S100 (20 mM HEPES, pH7.9, 500 mM NaCl,
1 mM EDTA, and 10% glycerol) and centrifuged at 20,000 x g for
10 minutes at 4uC. Protein in each of the two supernatants was
quantified using a Bradford protein assay (BioRad). The following
primary antibodies were used: monoclonal anti-HA (1:1000, Cell
Signaling), monoclonal anti-b-actin (1:40,000, Sigma) and poly-
clonal rabbit anti-human PARP-1 (1:4000, Alexis Biochemicals).
Secondary antibodies were IR680 conjugated goat anti-rabbit
(1:3000) and IR800 conjugated goat anti-mouse (1:10,000) from
Licor and Invitrogen, respectively. Visualization was performed
using a Licor Odyssey. Note that in Figure 3A, clones 1–4 were
run on a single gel, along with several other redundant clones.
Individual lanes were separated and displayed to illustrate the
range of hPARP-1 expression across which PARP-1 expression
confidently does not alter mADPR accumulation as measured by
TRPM2 dependent Ca
2+ transients.
Q-PCR: catalytic domainNA was prepared using the Qiagen
RNAeasy kit. Q-PCR was performed on a BioRad icycler using the
BioRad SYBR green master mix. The annealing temperature was
58uC. The following primers were used: hu/ck Parp F: gagtacgc-
caagagcgggc, hu/ck Parp R: atgggcgactgcaccatg, Beta Actin F:
tgagagggaaatcgtgcgtgacatc, Beta Actin R: caggaaagagggttggaaca-
gagcc. PARP-1 transcript level was normalized to b-actin and
PARP-WT expression using the DDCt method. Data analysis was
performed using Microsoft Excel and Graphpad Prism.
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